stelara Bio-Thera and Gedeon Richter partner to commercialize Stelara biosimilar BAT2206 By www.gabionline.net Published On :: Tue, 05 Nov 2024 09:14:16 +0000 <p>In October 2024, China based Bio-Thera Solutions (Bio-Thera) and Hungary’s Gedeon Richter announced they have reached an exclusive commercialization and license agreement for BAT2206, a biosimilar candidate to Johnson & Johnson’s Stelara (ustekinumab).</p> Full Article
stelara NICE backtracks to approve Janssen's Stelara in ulcerative colitis By www.pharmafile.com Published On :: Tue, 28 Apr 2020 10:20:00 +0000 NICE has recommended Janssen’s Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis (UC), a move which rows back on the Institute’s decision to reject the drug last year. Full Article Janssen NICE Research and Development Stelara ulcerative colitis Manufacturing and Production
